Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. www.questdiagnostics.com › healthcare-professionals › about-our-testsGenetics | Quest Diagnostics

    Quest Diagnostics offers an array of genetic (DNA) testing including oncology, neurology, exome, microarray, NIPT, and carrier screening. Skip to main content. ... Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies.

  2. www.questdiagnostics.com › locations › detailDetail | Quest Diagnostics

    852 Route 3. Ste 208. Clifton, NJ 07012. Phone 201-397-3918. Fax 973-458-8270. Schedule Online. Get Directions.

  3. www.questdiagnostics.com › patients › billing-insuranceInsurance | Quest Diagnostics

    Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services.

  4. Enter your zip code into our search tool to find a Quest Diagnostics location near you from where you can get your in-person testing administered. Skip to main content Skip to footer content. ... Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies.

  5. Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024. First quarter revenues of $2.37 billion, up 1.5% from 2023 First quarter reported diluted earnings per share ("EPS") of $1.72, down 3.4% from 2023; and adjusted diluted EPS of $2.04, flat with... 04 22 2024.

  6. Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of deidentified clinical ...

  7. 21 de oct. de 2021 · SECAUCUS, N.J., Jan. 12, 2022 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the fourth quarter and full year 2021. Fourth quarter 2021 results reflect higher than expected demand for COVID-19 testing services, while base testing volumes remained steady and consistent ...